Keywords: fda, orphan, status, sonus, tocosol, firm, pharmaceuticals

FDA orphan status for Sonus' TOCOSOL

Article | 31 January 2005

Print This

US firm Sonus Pharmaceuticals says that the Food and Drug Administration has granted an Orphan Drug designation to its lead ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in